
View larger version (18K):
[in a new window]
|
Fig. 4. A suggested model for the hSpry2-induced abrogation of EGFR endocytosis.
(A) Upon activation of EGFR, various tyrosine residues become phosphorylated
on the cytosolic tail of the receptor and they become targets of both positive
and negative regulatory proteins bearing intrinsic SH2 domains. Y1045 has the
surrounding motif FLQRY(1045)SSDPT. The atypical SH2 domain on
c-Cbl binds directly to Y1045. c-Cbl also functions as an E3 ubiquitin ligase
where it `tags' certain target proteins for ubiquitylation, endocytosis and
destruction via the intracellular endosomal system. In this case, c-Cbl
accepts ubiquitin from an E2 ligase to enzymatically polyubiquitylate the
EGFR, the first step in the downregulation process. A positive signal, by
which the Ras/MAP-kinase pathway gets activated, is initiated by the binding
of the Grb2 SH2 domain to tyrosine residues exemplified by Y1068. (B) When
hSpry2 is expressed in activated cells it translocates to the plasma membrane,
ostensibly by binding to free PtdIns(4,5)P2, and becomes
phosphorylated on Y55, which is imbedded in a motif similar to that around
Y1045 on the EGFR. The two tyrosine-phosphorylated sites on EGFR and hSpry2
therefore compete for binding to the SH2 domain of c-Cbl. Instead of EGFR
downregulation it appears that the interaction of c-Cbl and hSpry leads to
ubiquitylation and subsequent downregulation of hSpry2. The net result of this
is the failure of EGFRs to submit to endocytosis and destruction, thus
allowing the Ras/MAP-kinase signal to be sustained. (C) In the case of FGFR
signaling there is a similar balance between Ras/MAP-kinase activation and
signal inhibition. FGFRs require the constitutively associated docker protein
FRS2 to provide the appropriate tyrosine-phosphorylated sites. There are four
sites for Grb2 SH2-binding, represented by Y306, and two Shp2 SH2-binding
sites, represented by Y436. The Ras/MAP-kinase signal is channeled mainly
through the Shp2 pathway, whereas the directly bound Grb2 has associated c-Cbl
that is capable of ubiquitylating both FGFRs and FRS2. (D) When Spry is
expressed it translocates and binds to c-Cbl as described in B. The next part
of the model becomes descriptive rather than mechanistic, whereby the
Ras/MAP-kinase signal is inhibited possibly as a corollary of c-Cbl
associating via its SH2 domain to Y55 of Spry.
|